In this study, we also reported a significant elevation of liver damage markers (AST, ALT, and AP) in normal-weight NAFLD subjects; however, the liver damage markers were in the normal range with the progression of obesity in overweight and obese NAFLD subjects. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.